Objective: To evaluate the effectiveness of behavioural activation interventions for people with neurological conditions with comorbid depression, and explore content and adaptations. Data sources: PsycINFO, MEDLINE, CINAHL, AMED, and EMBASE databases were searched on the 19 November 2019. Reference lists of selected full-texts were screened by title. Review methods: We included peer-reviewed studies published in English that used behavioural activation for treatment of depression in adults with a neurological condition. Single-case reports, reviews, and grey literature were excluded. Methodological quality was assessed by two authors independently, and quality was appraised using Critical Appraisal Skills Programme checklists. Results: From 2714 citations, 10 articles were included comprising 590 participants. Behavioural activation was used to treat depression in people with dementia (n = 4), stroke (n = 3), epilepsy (n = 1), Parkinson's disease (n = 1), and brain injury (n = 1). Sample size ranged from 4 to 105 participants. There were seven randomized controlled studies; however, no studies compared behavioural activation to an alternative psychological therapy. The effect sizes varied between small and large in the studies where effect size could be calculated (d = 0.24-1.7). Methodological quality of the included studies was variable. Intervention components were identifying and engaging in pleasurable activities, psychoeducation, and problem-solving. Adaptations included delivering sessions via telephone, delivering interventions via primary caregivers, and giving psychoeducation to caregivers. Conclusion: The effectiveness of behavioural activation in randomized controlled trials varied from small to large (d = 0.24-1.7) in reducing depression. The content of behavioural activation was comparable to established treatment manuals. Adaptations appeared to support individuals to engage in therapy.
Introduction
People with neurological conditions experience higher rates of depression than those in other patient groups without neurological conditions. 1 Decreased social activities contribute to the continuation and exacerbation of depression through a loss of contact with contingencies that were previously reinforcing and mood enhancing. 2 Conversely, engagement in social and leisure activities for people with multiple sclerosis promotes positive mood and well-being. 3, 4 With depression and reduced or declining physical abilities (common in many neurological conditions), individuals find it difficult to identify with and engage in activities that have pleasurable or reinforcing consequences. 2 In the United Kingdom, National Institute of Health and Clinical Excellence recommends the use of cognitive-behavioural therapy for treating depression in individuals with chronic physical health problems (including neurological conditions). 5 However, cognitive-behavioural therapy is not best suited for people with neurological conditions, 6 because many have cognitive difficulties that may make accessing and engaging with cognitive-behavioural therapy difficult. 7 Therefore, adapting psychological therapies to better consider the interaction of comorbid psychological and physical conditions may be more acceptable to people with neurological/physical health conditions. 8 Behavioural activation is a type of psychological therapy that encourages individuals with depression to engage in activities they have been avoiding. Individuals define goals and activity schedules. 9 Behavioural activation is a relatively simple, easy to understand intervention that does not require a highly trained therapist or complex skills from the patient, 10 and may be suitable for individuals with cognitive and physical difficulties.
In non-neurological populations, the behavioural activation component of cognitive-behavioural therapy is as effective alone compared with when used in combination with cognitive aspects 11 -and has been found to be as effective as antidepressant medication. 12 A meta-analysis of activity scheduling (a type of behavioural activation) interventions for the treatment of depression found a pooled effect size (d) of 0.87, favouring activity scheduling over waitlist or placebo controls or alternative psychological therapies (95% confidence interval: 0.60-1.15). 13 Behavioural activation is also considered cost-effective for depression. 14 However, the evidence for the effectiveness of behavioural activation in people with neurological conditions is inconclusive.
Therefore, this review aimed to (1) report the evidence of the effectiveness of behavioural activation interventions for individuals with neurological conditions with comorbid depression, with outcomes of interest being mood, function, activity, and quality of life; (2) describe the content of behavioural activation interventions; and (3) identify the adaptations made to the behavioural activation intervention specifically for people with neurological conditions.
Method
We followed the Preferred Reporting Items for Systematic review and Meta-Analysis Protocols (PRISMA-P) 2015 guidelines 15 and the protocol was prospectively registered on PROSPERO (CRD42018102604).
The following online databases were searched: Medline (1970-present), CINAHL (1970-present), PsycINFO (1970-present) , EMBASE (1980-present), and AMED (1980-2019). The last search was completed on 19 November 2019. The following keywords were used: Behavioural activation, behaviour therapy, activity scheduling, depression, and neurological conditions. We used variations of these terms including medical subject headings (MeSH) where available. For a complete list of the search terms, please refer to Supplemental Appendix A. Terms were 'exploded' and used singularly or in conjunction with similar terms based on the database being searched. The reference lists of the selected full-texts were screened by title, as an additional way of identifying relevant articles.
Included studies were peer-reviewed, quantitative, or qualitative, and published in English. Studies were required to include (a) behavioural activation for treatment of depression (clinician confirmed diagnosis or scoring above defined thresholds on validated depression measures); (b) adults (⩾16 years) with a neurological condition, defined as a condition or disease of the brain, as a result of illness or injury. Studies using behavioural therapy were included where the use of activity scheduling and monitoring was of primary focus, which was defined as the targeting of behavioural avoidance and increasing contact with environmental positive reinforcement. We were primarily interested in clinical effectiveness of the intervention on the patient, but we also included outcomes that related to the caregiver. We excluded articles that were policy papers, books, theses, or conference proceedings.
Data extraction was completed by the first author and accuracy was checked by the other authors. Supplemental Table S1 summarizes the data extracted. Following the database searches, results were transferred to Microsoft Excel and duplicates were removed. The first author screened titles and abstracts, before reviewing full-text articles. Data extraction was completed using a predefined template informed by the reader's guide to critical appraisal of cohort studies [16] [17] [18] (for the template headings, please see Supplemental Appendix B).
Following PRISMA guidance, [16] [17] [18] the first and one other author independently assessed the methodological quality of each included article. Discrepancies were resolved through discussion. The quality appraisal framework selected was informed by the study design of the included articles: Critical Appraisal Skills Programme Randomized Controlled Trials checklist, 19 cohort studies checklist, 20 qualitative checklist, 21 and Mixed Methods Appraisal Tool -Version 2011. 22 A narrative summary for data analysis was conducted due to the low number of articles identified.
A meta-analysis was not considered because we only had a small number of studies, with considerable heterogeneity in terms of study designs, outcome measures, and measurement time points. Therefore, to compare and synthesize effectiveness data, effect size estimates were used (with effect size determined from study data when not reported). Where multiple depression measures were used, the primary measure was used. Through conversion into standardized between-condition effect sizes, we treat studies as comparable with respect to the comparison condition (e.g. that usual care is similar across studies); however, if comparators (e.g. forms of 'usual care') differ systematically across studies, then this assumption (of transitivity) would be violated: the treatment effect will not be defined independently of individual comparators (i.e. there will be a treatment-by-study interaction).
Results
Initial database searches identified 2714 articles, 49 full-text articles were considered for inclusion, and 10 articles (with 590 participants) met our inclusion criteria. Figure 1 is the PRISMA flow diagram.
All included articles were quantitative intervention studies: seven randomized controlled trials, [23] [24] [25] [26] [27] [28] [29] one cohort study, 30 and two multiple baseline experimental design studies. 31, 32 The articles were published between 1991 and 2019, based on studies from the United States, 23, [26] [27] [28] [29] [30] [31] [32] the United Kingdom, 24 and Australia. 25 The components and format of the behavioural activation interventions are summarized in Supplemental Table S1 , which also describes the clinical context of each intervention, and the comparator groups (where used).
The quality of the studies, as seen in Table 1 , was variable. All had a clearly stated aim and identified their target sample. Participant demographics were adequately detailed in almost all studies, but one. 32 Studies and sample representativeness varied from low to high. Sample sizes ranged from 4 to 105 participants. 24, 32 The quality of reporting of the studies also varied. In randomized controlled trials, the method of randomization was reported in all but one study, 23 with most studies using computer-generated algorithms. [24] [25] [26] [27] [28] [29] [30] 32 In five randomized controlled trials, assessors were blinded to participant group allocation; 23, [26] [27] [28] [29] in one study, assessors were only blinded to secondary measures; 24 and in one study, there was no blinding of data collection. 25 Only two studies reported data on treatment fidelity, 24, 30 with most studies collecting no or minimal data on the delivery of the intervention. 23, [25] [26] [27] [28] [29] 31, 32 All studies included or described data pertaining to the validity and reliability of assessment measures.
Additional sources of possible methodological biases were evident, such as reporting bias (not detailing all outcomes), 27 use of self-report methods to assess depression, [23] [24] [25] [26] [27] [28] [30] [31] [32] and caregivers completing depression assessments on the participants' behalf. 23, 31, 32 One study 31 used a singlecase experimental design but did not report any statistical analysis or present any data for depression. One study 32 used a single-case experimental design but did not consistently establish a baseline before introducing the intervention, as recommended by multiple single case experimental design standards. 33 Variants of behavioural activation processes, such as activity scheduling or monitoring, were used in samples with dementia, 23, 25, 31, 32 stroke, 24, 27, 28 epilepsy, 26 Parkinson's disease, 30 and brain injury. 29 Participants were recruited from nursing homes, hospital clinics, and the community. The mean age range was 38.5-86.5 years. A number of studies recruited patient-caregiver dyads and investigated the effects of using paid and unpaid caregivers as intervention aids. 23, 25, 31, 32 In addition, studies reported the impact of behavioural activation for patients, on caregivers' depression, quality of life, and/or perceived burden. 23, 30, 32 The following assessments were used to assess depression outcomes: the Cornell Scale for Depression in dementia, 23, 31, 34 the Hamilton Depression Rating Scale, 23, 27, 28, 32, 35 Stroke Aphasic Depression Questionnaire 21-Item Hospital Version, 24, 36 Geriatric Depression Scale-12, 25, 27, 28, 30, 37 the Patient Health Questionnaire, 29, 38 and the Hopkins Symptom Checklist -20. 26, 39 Caregiver depression was consistently assessed using the Hamilton Depression Rating Scale. 23, 32, 35 Seven studies used comparator groups; six used a two-arm design, of which, four used usual care for one arm, 24,26-28 one used a walking and talking intervention as a comparison group, 25 and one used a motivation intervention. 29 Another study 23 had four arms (behavioural therapy and pleasant events, behavioural therapy and problem-solving, usual care, and waitlist control). Attrition rates were reported for all studies and ranged from 5% 25 to 27%. 31 In terms of effectiveness (aim 1) 8 of 10 studies reported a positive outcome for behavioural activation in terms of improving depressive symptoms. 23, 24, 26, [28] [29] [30] [31] [32] In studies reporting effects favouring the intervention, estimable effect size ranged from d = 0.38-1.7 (for parity, where multiple follow-up assessments were reported, the first post-intervention effect estimate was selected). When the lowest quality studies were not considered (i.e. limiting to previous literature 23, 24, 26, 28 ), the effect size range remained the same.
Conversely, two studies did not favour behavioural activation, reporting non-superiority for reducing depression relative to usual care (d at first (8 week) follow-up = 0.24, p = 0.30) 27 or a walkingand-talking intervention (d not reported, p = 0.61). 25 Overall, across the six studies for which effect sizes were estimable, 23, 24, [26] [27] [28] 30 effects of behavioural activation ranged widely at first follow-up (post-intervention): from small-to-large magnitude (ds = 0.24-1.7). The same range (ds = 0.24-1.7) was observed when limiting to the five studies that estimated effect size against a comparator; 23, 24, [26] [27] [28] all these effects were estimated relative to a usual care condition, in a randomized controlled trial design, although the nature of 'usual care' likely differs across populations and between individual studies.
Considering findings by population, there was at least one favourable finding for each study population. Behavioural activation treatment was favoured in three of four dementia-focussed studies (observed ds = 0.9-1.7 (at first follow-up)) and two of three stroke-focussed studies (largest observed ds = 0.24-1.17), with favourable findings in each of the (single) studies examining effects for patients with epilepsy (d = 0.38), Parkinson's disease (d = 0.70), and brain injury (d unreported).
In terms of effect sizes at longer term follow-ups, four randomized controlled trials 24,26-28 provided estimates of effect size (comparing behavioural activation with usual care) at 5-6 months: these ranged from negligible (0.05) 27 to moderate (0.77) 24 magnitude. Of the four randomized controlled trials, three further provided estimates of effect size at 12 months, and these again ranged from negligible (0.10) 27 to moderate (0.70) 26 magnitude.
Further to effects on patient outcomes, there were reported benefits of patient-focused behavioural activation on caregivers' depression in two studies 23, 32 (reduced caregiver depression on the Hamilton Depression Rating Scale). Another study 24 found no significant effects of patientfocussed behavioural activation on caregiver strain or leisure activities -although caregivers expressed high satisfaction with the care provided.
In terms of content (aim 2), behavioural activation interventions included the use of psychoeducation, identifying pleasurable activities, scheduling pleasant activities, graded task assignments, and problem-solving. The interventions were delivered by study therapists, care home staff, master's degree students, and unpaid caregivers. In one study, behavioural activation was delivered in two formats (face-to-face and telephone) and was compared with usual care; 27 however, due to low recruitment numbers and being under-powered, the interventions arms were combined and compared with usual care. Across studies, the number of sessions delivered ranged from one 29 to twenty, 24 with most studies delivering between six and nine sessions. [23] [24] [25] [26] [27] [28] 30, 32 Where reported, the duration of sessions ranged from 10 minutes 27,30 to 1 hour. 23, 24, 32 The duration of the intervention in most studies was 1 hour. One study used a single session followed by eight weeks of daily text messages. 29 With respect to aim 3, few adaptations were made to the content of the delivered behavioural activation intervention. Where adaptations were made, the most frequent addition to the programme was problem-solving. [25] [26] [27] [28] In one study, the problem-solving content was focused on the behavioural challenges, presented by patients with dementia, whereas one study used problem-solving to support access to pleasant activities. 25 Carers were involved in four studies. For instance, psychoeducation was delivered to the caregiver rather than the patient, 23, 32 or caregivers (paid and unpaid) assisted in the delivery of behavioural activation 23, 25, 31, 32 or to support access to pleasant activities. 25, 31 Where caregivers were used to deliver behavioural activation, reduction in low mood for patients was shown in two studies, 23, 32 but mixed results were found in relation to reduction in patient depression when paid caregivers supported access to pleasant activities.
Finally, the method of delivery in all studies was one-to-one, and no group studies were identified. In one study, 32 both the caregivers and patients attended sessions, with the first three sessions attended by both parties, and the remaining five sessions attended only by caregivers. In all but two studies, 26, 30 sessions were delivered face-to-face. However, one study used a single face-to-face session followed by a series of text messages; the content of the messages having been agreed during the initial session. 29 In one study, 27 one treatment arm received telephone contact; however, the results were combined with the face-to-face arm and compared with usual care.
Discussion
Overall, we found some indication that behavioural activation is effective in the treatment of depression in individuals with neurological conditions with effects maintained beyond a six-month period. Behavioural activation had a varied effect between small and large in the studies where effect size could be calculated (d = 0.24-1.7, in six of seven randomized controlled trials) in reducing depression. The largest effect size includes the combined reporting of the intervention arms of behavioural therapy pleasant events and behavioural therapy problem-solving, 23 when excluding the combined intervention arms the same varied range of small to large effect sizes were observed across included articles. This finding is consistent with a previous meta-analysis, which concluded that behavioural activation for depression in individuals without a neurological condition is effective (d = 0.87). 13 In our review, participants with Parkinson's disease or epilepsy benefitted the most on depression, quality of life, and apathy outcomes. In studies with dementia or stroke samples, varying levels of effectiveness were found. However, these results should be treated with caution, because the quality of some studies was not optimal.
Most studies reported statistically significant differences in the reduction of depression, but effect sizes were not reported in all cases. The variance in the reported outcomes may be a result of the design and delivery of the intervention, clinical condition, outcome measures, timing of assessments, and comparators (or lack thereof). The good-quality studies suggested that behavioural activation was clinically and cost effective, and they were reported in a way that would enable replication. The findings from the other studies, however, must be treated with caution because depression was not always the primary presenting difficulty. Furthermore, studies had small sample sizes. Only 5 of 10 studies conducted a sample size calculation or power analysis, 24, [26] [27] [28] 30 and 3 studies did not reach their recruitment target. 24, 26, 27 Half of the trials included follow-ups of six months or longer. 23, 24, [26] [27] [28] This is beneficial as it provides an insight into continued benefits of the intervention. All but one 27 -which had no significant benefits in depression outcomes at the end of treatment -reported significant continued benefits at long-term follow-up.
Few studies reported making any adaptations to the intervention specifically for the populations studied. Where adaptations were mentioned, these included adding a problem-solving component to the behavioural activation intervention, delivering sessions by telephone, and teaching caregivers (paid and unpaid) to facilitate behavioural activation and provide access to pleasurable activities.
One study added a problem-solving component to standard behavioural activation, but it was unclear whether this additional component was specific to overcoming barriers to activities or providing support for individuals' difficulties in dayto-day tasks. A more generic problem-solving approach may have introduced a deviation from behavioural therapy interventions. A lack of fidelity assessment and assessment of participant adherence makes it difficult to determine what the participants actually received in terms of 'content' and the 'dose' of the intervention. Where reported, the average number of pleasant activities completed increased significantly (p < 0.005) from baseline, and a significant positive relationship between depressed mood and duration and frequency of pleasant events was identified (mean = 0.72, SD = 0.16, t(3) = 2.07, p < 0.08).
In terms of intervention delivery format, we were not able to determine the relative effectiveness of telephone versus face-to-face delivery, as only one study made this comparison, and the outcomes did not differ significantly from each other; however, data were not presented detailing the comparison. Two studies reported a medium effect size in the reduction of depression using a combination of face-to-face and telephone (d = 0.70), which suggests that telephone as a mode of delivery may be of benefit to individuals, particularly because some may experience physical difficulties and may struggle to attend appointments. Behavioural activation sessions varied in number and length of sessions. In clinical settings, the variability may support clinicians and services with limited resources. However, more research is needed to investigate the effectiveness of behavioural activation in fewer sessions.
Using unpaid caregivers to support the delivery of behavioural activation may be a benefit to both the person with a neurological condition and the caregiver themselves. Caregivers experienced a reduction in depression, but behavioural activation had no impact on perceived strain/burden. This may be because the person they care for continues to have care needs, with or without the presence of depression, which the caregiver continues to facilitate. Indeed, high care need is associated with higher levels of caregiver strain and poorer quality of life. 40 One strength of this review is that the search strategy was tested, and the search terms were refined with a specialist study librarian before the final search, which increased the likelihood of identifying articles. The electronic search and hand search of full-text reference lists increases confidence that most relevant research was included in this systematic review and that the conclusions made in the review are based on a synthesis of available evidence.
Our findings, however, must be viewed in light of the review's limitations. We could only find a small number of studies to include, and many of the studies had small sample sizes, and considered few neurological conditions. None of the studies compared behavioural activation with another psychological or pharmacological intervention; therefore, no direct comparisons of effectiveness were possible. Only peer-reviewed literature was included and as a result the exclusion of unpublished findings may bias the results to demonstrate a positive effect of the intervention. This exclusion criterion was applied to ensure that only methodological robust studies were included. When considering the potential of publication bias, future reviews might benefit from including grey literature. Finally, only one author screened articles for inclusion.
Future research should consider and address methodological and conceptual limitations of published studies as highlighted in this review. For example, data should be reported for each arm of randomized controlled trials. Studies should assess the fidelity of the delivery of the behavioural activation intervention, and activity participation should be recorded as an outcome to determine whether changes are directly related to behavioural activation. A fully powered randomized controlled trial with longer term follow-ups, and head-to-head comparisons with alternative psychological therapies, with an evaluation of the cost-effectiveness, to determine which is most effective intervention is warranted.
Clinical messages
• • There is some evidence that behavioural activation is beneficial in reducing depressive symptoms in several neurological conditions, although the low quality of studies means the findings should be interpreted with caution.
• • Behavioural activation interventions
have been delivered in a number of formats such as telephone, face-toface, and carer supported, with varying number and length of sessions.
